KR960003724A - 간질환 치료용 약제조성물 - Google Patents

간질환 치료용 약제조성물 Download PDF

Info

Publication number
KR960003724A
KR960003724A KR1019940017855A KR19940017855A KR960003724A KR 960003724 A KR960003724 A KR 960003724A KR 1019940017855 A KR1019940017855 A KR 1019940017855A KR 19940017855 A KR19940017855 A KR 19940017855A KR 960003724 A KR960003724 A KR 960003724A
Authority
KR
South Korea
Prior art keywords
pharmaceutical composition
formula
compound
weight
parts
Prior art date
Application number
KR1019940017855A
Other languages
English (en)
Other versions
KR0142809B1 (ko
Inventor
선종건
Original Assignee
선종건
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 선종건 filed Critical 선종건
Priority to KR1019940017855A priority Critical patent/KR0142809B1/ko
Publication of KR960003724A publication Critical patent/KR960003724A/ko
Application granted granted Critical
Publication of KR0142809B1 publication Critical patent/KR0142809B1/ko

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

본 발명은 간질환 치료제로서 유용한 다음 구조식(1)의 비페닐 디메칠 디카복시레이트(DDB)와 다음 구조식(2)의 우르소데옥시콜린산(UDCA)을 함유한 약제조성물에 관한 것이다.

Description

간질환 치료용 약제조성용
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (5)

  1. 다음 구조식(1)로 표시되는 비페닐디메칠 디카복시레이트(DDB)와 다음 구조식(2)로 표시되는 우르소데옥시콜린산(UDCA) 및 약제학적으로 허용되는 부형제로 이루어진 것을 특징으로 하는 약제조성물.
  2. 제1항에 있어서, 상기 구조식(1) 화합물은 폴리소르베이트 80과 폴리에칠렌글리콜 6000를 사용하여 통상의 용융-용매법으로 처리한 것임을 특징으로 하는 약제조성물.
  3. 제1항에 있어서, 상기 구조식(1) 화합물과 구조식(2) 화합물의 유효량은 각각 7∼30 중량부와 30∼100중량부로 혼합된 것임을 특징으로 하는 약제조성물.
  4. 제1항에 있어서, 상기 구조식(1) 화합물의 유효량이 25중량부이고, 구조식(2) 화합물의 유효량이 50중량부임을 특징으로 하는 약제조성물.
  5. 제1항에 있어서, 상기 구조식(2) 화합물의 유효량이 12.5 중량부이고, 구조식(2) 화합물의 유효량이 50중량임을 특징으로 하는 약제 조성물.
KR1019940017855A 1994-07-23 1994-07-23 간질환 치료용 약제조성물 KR0142809B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019940017855A KR0142809B1 (ko) 1994-07-23 1994-07-23 간질환 치료용 약제조성물

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019940017855A KR0142809B1 (ko) 1994-07-23 1994-07-23 간질환 치료용 약제조성물

Publications (2)

Publication Number Publication Date
KR960003724A true KR960003724A (ko) 1996-02-23
KR0142809B1 KR0142809B1 (ko) 1998-07-15

Family

ID=19388643

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940017855A KR0142809B1 (ko) 1994-07-23 1994-07-23 간질환 치료용 약제조성물

Country Status (1)

Country Link
KR (1) KR0142809B1 (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100626414B1 (ko) * 2003-08-27 2006-09-20 선종건 간염 치료용 약제조성물

Also Published As

Publication number Publication date
KR0142809B1 (ko) 1998-07-15

Similar Documents

Publication Publication Date Title
KR950014073A (ko) 이소퀴놀린
ES8705393A1 (es) Un procedimiento para preparar un derivado de pirazol (como divisional de la solicitud de patente de invencion n 543.046, presentada el 10.5.85)
KR950017957A (ko) 3, 4, 4-삼치환-피페리디닐-n-알킬카르복실레이트의 제법 및 중간체
IT1252868B (it) Composizione farmaceutica anticefalalgica per somministrazione endonasale, procedimento per prepararla e suo impiego terapeutico
DE69713526D1 (de) Lösliche prodrugs von paclitaxel
RU95113862A (ru) Производные пирролопиримидинов, фармацевтическая композиция, промежуточные соединения
KR890011837A (ko) 디데하이드로 비타민 d₃유도체
BR9401183A (pt) Composto e formulação farmacêutica
BR9814498A (pt) Processo para o tratamento de obesidade em um humano necessitando de tal tratamento, composto, uso do mesmo, produto, e, composição farmacêutica
EA199800013A1 (ru) Способы минимизации остеопороза
RU2218334C2 (ru) Замещенные 1,2,3,4,5,6-гексагидро-2,6-метано-3-бензазоцин-10-олы и фармацевтическая композиция на их основе
ATE107167T1 (de) Pharmazeutische zubereitungen für neuroschutz, die arylcyclohexylamine enthalten.
KR900009606A (ko) 불소-함유 2-니트로 이미다졸 유도체 및 그를 함유하는 방사선 증감제
ATE90339T1 (de) Basisch substituierte phenylacetonitrile, ihre herstellung und diese enthaltende arzneimittel.
KR950703941A (ko) 일산화질소 합성 억제제(nitrogen monoxide synthesis inhibitor)
ATE17727T1 (de) Alkylenverbrueckte guanidinothiazolderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel.
KR960003724A (ko) 간질환 치료용 약제조성물
FI834800A0 (fi) Foerfarande foer framstaellning av dialkylaminoalkoxibensylalkohol-derivat
CA2249756A1 (fr) Nouveaux composes de l'indanol, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
KR970705999A (ko) 타목시펜 및 타목시펜 유사체의 자궁향성 효과를 최소화시키는 방법 (a method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs)
KR890008079A (ko) 치환된 디카복실산- 비스(3, 5- 디카바모일- 2, 4, 6- 트리요오도아닐리드), 이의 제조방법 및 이를 함유하는 x- 선 조영제
CA2231025A1 (fr) Nouveaux composes de 2-amino indane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
RU95104235A (ru) Агент для контроля плодовитости и содержащая его фармацевтическая композиция
KR910019974A (ko) 치환된 인돌
BR9507135A (pt) Composto uso do mesmo processo de preparação do mesmo composição farmacêutica e composição cosmética

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
J204 Request for invalidation trial [patent]
J121 Written withdrawal of request for trial
FPAY Annual fee payment

Payment date: 20130403

Year of fee payment: 16

FPAY Annual fee payment

Payment date: 20140521

Year of fee payment: 17

EXPY Expiration of term